18 nov
|
Alexion Pharmaceuticals,Inc.
|
Barcelona
18 nov
Alexion Pharmaceuticals,Inc.
Barcelona
Alexion, AstraZeneca Rare Disease is seeking a Director to lead integral value, access and pricing for Haematology indications, with a focus on PNH and HSCT-TMA. This strategic role requires deep HTA and payer experience and cross‑functional collaboration across regions.
You will influence lifecycle management, support country access representatives and lead payer discussions to optimize patient access to transformative therapies. Date posted 11‑nov‑2026; closing 29‑nov‑2026.
📌 Global Haematology Access Lead (Barcelona)
🏢 Alexion Pharmaceuticals,Inc.
📍 Barcelona